DNTH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dianthus Therapeutics Inc

Watchlist Manager

Watchlist

Price: 75.215 USD 4.33% Market Closed

Market Cap: $4.1B

	Dianthus Therapeutics Inc NASDAQ:DNTH	US
	Mainstreet Equity Corp F:9V4	CA
	Sino Harbour Holdings Group Ltd HKEX:1663	CN
E	Electricite de Strasbourg SA F:7Z2	FR
	Dycom Industries Inc NYSE:DY	US
C	Cadence Design Systems Inc XMUN:CDS	US

Profitability Summary

Dianthus Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-11,441%

Negative 3Y Average Operating Margin

-4,636%

Declining Operating Margin

-2,403% > -11,441%

Negative Net Margin

-10,097%

Negative 3Y Average Net Margin

-4,125%

Declining Net Margin

-2,243% > -10,097%

Negative Free Cash Flow Margin

-8,178%

Negative 3Y Average Free Cash Flow Margin

-3,279%

Declining Free Cash Flow Margin

-1,764% > -8,178%

Negative ROE

-26%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-533%

ROIC is Increasing

-331% > -114%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.